002019.SZ · 亿帆医药
China A-shares · RS rating 32 · As of 2026-10-14
| Price | 9.43 CNY |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 32 / 65 / 45 / 20 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 21 / 23 / 20 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -3.5% |
| Distance from 52-week high | +34.7% |
| Market cap (USD) | $1.8B |